Laurion Capital Management LP

Position in CRDF — Cardiff Oncology, Inc.

CIK 1390202 NEW YORK, NY

Position in CRDF

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$4,287,715

-$3,149,618 QoQ

Shares Held

2,646,738

0.0% QoQ

Ownership

3.87%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Laurion Capital Management LP holds $248,360,790 across 18 Biotechnology names. CRDF ranks #10 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,262,651	$93,764,463
2	MLYS	Mineralys Therapeutics, Inc.	2,232,040	$60,465,963
3	NUVB	Nuvation Bio Inc.	7,822,638	$33,559,117
4	BBOT	BridgeBio Oncology Therapeutics, Inc.	1,922,656	$17,207,771
5	PYXS	Pyxis Oncology, Inc.	4,997,333	$7,296,106
6	VOR	Vor Biopharma Inc.	318,670	$5,685,072
7	PEPG	PepGen Inc.	2,750,855	$4,869,013
8	AUTL	Autolus Therapeutics plc	3,316,626	$4,576,943

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,287,715	2,646,738	0.0%	Shares	Sole	2026-05-14
2025-12-31	$7,437,333	2,646,738	+7.3%	Shares	Sole	2026-02-17
2025-09-30	$5,079,696	2,465,872	+37.2%	Shares	Sole	2025-11-17
2025-06-30	$5,661,438	1,797,282	+96.2%	Shares	Sole	2025-08-14
2025-03-31	$2,876,911	916,214	+58.8%	Shares	Sole	2025-05-15
2024-12-31	$2,503,850	576,924	-37.9%	Shares	Sole	2025-02-14
2024-03-31	$4,959,348	928,717	+28.6%	Shares	Sole	2024-05-15
2023-12-31	$1,068,708	722,100	0.0%	Shares	Sole	2024-02-14
2023-09-30	$1,003,719	722,100	0.0%	Shares	Sole	2023-11-14
2023-06-30	$1,061,487	722,100	0.0%	Shares	Sole	2023-08-14
2023-03-31	$1,191,465	722,100	0.0%	Shares	Sole	2023-05-15
2022-12-31	$1,010,940	722,100	0.0%	Shares	Sole	2023-02-14
2022-09-30	$1,112,034	722,100	0.0%	Shares	Sole	2022-11-14
2022-06-30	$1,588,620	722,100	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.